Disparities Among Liver Transplant Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-15

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hepatic Transplantation Registry

NCT05944042

Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors

RECRUITING

Donor and Recipient Mismatch in Liver Transplantation

NCT07250919

Patient Survival Graft Survival Liver Disease (Alcoholic or Not) +1 more

COMPLETED

Adult-to-Adult Living Donor Transplant Cohort Study

NCT01619475

Liver Diseases Hepatocellular Cancer End Stage Liver Disease +2 more

COMPLETED

Reducing Disparities in Living Donor Transplant Among African Americans

NCT03819686

Kidney Transplant

COMPLETED NA

Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over

NCT04754503

Patients Suitable for a Liver Transplant

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction.

Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender).

Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End Stage Liver DIsease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Liver Transplant Patients

Subjects with end-stage liver disease and being referred for transplant evaluation will fill out questionnaires about their background, emotions, and behaviors.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients with end-stage liver, kidney, or cardiac dysfunction.

Exclusion Criteria

* Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
* Patients with potential medical exclusions for transplant.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No